Literature DB >> 22956734

Comparative analysis of the fusion efficiency elicited by the envelope glycoprotein V1-V5 regions derived from human immunodeficiency virus type 1 transmitted perinatally.

Hongyan Guo1,2, Levon G Abrahamyan3, Chang Liu2, Mackenzie Waltke3, Yunqi Geng1, Qimin Chen1, Charles Wood3, Xiaohong Kong2.   

Abstract

Understanding the properties of viruses preferentially establishing infection during perinatal transmission of human immunodeficiency virus type 1 (HIV-1) is critical for the development of effective measures to prevent transmission. A previous study demonstrated that the newly transmitted viruses (in infants) of chronically infected mother-infant pairs (MIPs) were fitter in terms of growth, which was imparted by their envelope (Env) glycoprotein V1-V5 regions, than those in the corresponding chronically infected mothers. In order to investigate whether the higher fitness of transmitted viruses was conferred by their higher entry efficiency directed by the V1-V5 regions during perinatal transmission, the fusogenicity of Env containing V1-V5 regions derived from transmitted and non-tranmsmitted viruses of five chronically infected MIPs and two acutely infected MIPs was analysed using two different cell-cell fusion assays. The results showed that, in one chronically infected MIP, a higher fusion efficiency was induced by the infant Env V1-V5 compared with that of the corresponding mother. Moreover, the V4-V5 regions played an important role in discriminating the transmitted and non-transmitted viruses in this pair. However, neither a consistent pattern nor significant differences in fusogenicity mediated by the V1-V5 regions between maternal and infant variants was observed in the other MIPs. This study suggests that there is no consistent and significant correlation between viral fitness selection and entry efficiency directed by the V1-V5 regions during perinatal transmission. Other factors such as the route and timing of transmission may also be involved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22956734      PMCID: PMC4091294          DOI: 10.1099/vir.0.046771-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  44 in total

1.  Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.

Authors:  A Bültmann; W Muranyi; B Seed; J Haas
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.

Authors:  H G Guo; F M Veronese; E Tschachler; R Pal; V S Kalyanaraman; R C Gallo; M S Reitz
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

3.  HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures.

Authors:  Keila Correia Alcântara; Janaína Bacelar Accioli Lins; Maly Albuquerque; Letícia Mara Aires; Ludimila Paula Vaz Cardoso; Ana Lúcia Minuzzi; Mariane Martins Araújo Stefani
Journal:  J Clin Virol       Date:  2012-02-06       Impact factor: 3.168

4.  Vertical transmission of Kaposi's sarcoma-associated herpesvirus.

Authors:  H Mantina; C Kankasa; W Klaskala; B Brayfield; J Campbell; Q Du; G Bhat; F Kasolo; C Mitchell; C Wood
Journal:  Int J Cancer       Date:  2001-12-01       Impact factor: 7.396

5.  Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41.

Authors:  I Muñoz-Barroso; S Durell; K Sakaguchi; E Appella; R Blumenthal
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

6.  Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility.

Authors:  Marie Pancera; Shahzad Majeed; Yih-En Andrew Ban; Lei Chen; Chih-chin Huang; Leopold Kong; Young Do Kwon; Jonathan Stuckey; Tongqing Zhou; James E Robinson; William R Schief; Joseph Sodroski; Richard Wyatt; Peter D Kwong
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

7.  Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers.

Authors:  G Scarlatti; T Leitner; E Halapi; J Wahlberg; P Marchisio; M A Clerici-Schoeller; H Wigzell; E M Fenyö; J Albert; M Uhlén
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.

Authors:  E Fenouillet; I M Jones
Journal:  J Gen Virol       Date:  1995-06       Impact factor: 3.891

9.  Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease.

Authors:  Hong Zhang; Federico Hoffmann; Jun He; Xiang He; Chipepo Kankasa; John T West; Charles D Mitchell; Ruth M Ruprecht; Guillermo Orti; Charles Wood
Journal:  Retrovirology       Date:  2006-10-20       Impact factor: 4.602

10.  Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics.

Authors:  Kara G Lassen; Michael A Lobritz; Justin R Bailey; Samantha Johnston; Sandra Nguyen; Benhur Lee; Tom Chou; Robert F Siliciano; Martin Markowitz; Eric J Arts
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

View more
  1 in total

1.  Critical amino acids within the human immunodeficiency virus type 1 envelope glycoprotein V4 N- and C-terminals contribute to virus entry.

Authors:  Yan Li; Dan Yang; Jia-Ye Wang; Yuan Yao; Wei-Zhe Zhang; Lu-Jing Wang; De-Chun Cheng; Feng-Kun Yang; Feng-Min Zhang; Min Zhuang; Hong Ling
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.